Algo version: 0.98b
EYES is listed at the NASDAQ Exchange
EYES [EYES]
NASDAQ Sector: Healthcare Industry:Medical - Devices

Is EYES stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Second Sight Medical 10 years ago, but if you had invested on Wednesday 19th of November 2014 when the price was $19.97, you would have made a loss of $-15.83 per share or -79.27%

No, the average daily trading liquidity for Second Sight Medical is $574 230 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Second Sight Medical has no real debt, which is good in periods of high inflation. Second Sight Medical has a very good net profit margin of 6 871.54% and should have very high tolerances against inflation.

We have calculated the inflation risk for Second Sight Medical to be low [0.3 out of 1]